Cheng Zhang

12PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
Tinengotinib (TT-00420) inhibits tumor growth and overcomes multidrug resistance in gastrointestinal cancers.

|Oct 06, 2025
SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts.

Shengde Liu, Zizhen Zhang, Zhenghang Wang

|May 15, 2025
Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancer.

Mei He, Congcong Ji, Zhiwei Li

|Apr 10, 2025
Emerging Strategies of Cell and Gene Therapy Targeting Tumor Immune Microenvironment.

Runtian Wang, Xiaorui Duan, Jian Li

|Jun 21, 2023
ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.

Fangli Jiang, Keren Jia, Yang Chen

|Dec 03, 2022
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft.

Mengqi Zhang, Beifang Li, Haiyan Liao

Pageof 2

Frequent Collaborators

6 joint publications

Lin Shen

3 joint publications

Xiaoyi Chong

2 joint publications

Zuhua Chen

2 joint publications

Jian Li